Background: In December of 2019, a new form coronavirus was discovered in Wuhan,China. Signs and symptoms it include tiredness, cough, fever . Another common symptom this respiratory disease is the loss smell. Objective: To find frequency anosmia COVID-19 patients our community relation to other communities determine clinical outcome affected by Patients Methods: This cross-sectional study at K...

Objectives This is a protocol for Cochrane Review (intervention). The objectives are as follows: To assess the effects (benefits and harms) of interventions to treat olfactory dysfunction in people with COVID‐19 infection. A secondary objective maintain currency evidence, using living systematic review approach.

Viral upper respiratory infections are the most common cause of clinical olfactory dysfunction, but the pathogenesis of dysosmia after viral infection is poorly understood. Biopsies of the olfactory mucosa in patients that complain of dysosmia after viral infection fall into two categories: one in which no olfactory epithelium is seen and another in which the epithelium is disordered and popula...

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is a rare, heritable, small vessel vascular disease caused by mutations in the Notch3 gene that is characterized by migraines, subcortical vascular events, cognitive decline, and mood disturbances. However, many CADASIL cases present with unusual symptoms such as status epilepticus, a movement d...